Literature DB >> 8365601

Treatment of non-extractable common bile duct stones with combination ursodeoxycholic acid plus endoprostheses.

G K Johnson1, J E Geenen, R P Venu, M J Schmalz, W J Hogan.   

Abstract

Despite widely available technology for removal of bile duct stones, endoscopists currently encounter approximately 3% of patients with stones that defy extraction. After sphincterotomy and unsuccessful attempts at extraction of "defiant" stones, biliary stents were placed in 22 patients. Ten patients were treated with ursodeoxycholic acid, and 12 patients treated only with stent served as control subjects. Ductal strictures preventing stone extraction were present in eight control patients and in six patients treated with ursodeoxycholic acid. The number of total calculi in the ursodeoxycholic acid group was slightly higher (4.2 per patient) than the number in the control group (3.3 per patient). Stone and bile duct dimensions were similar in each group. Nine of 10 patients in the ursodeoxycholic acid group had complete stone clearance, and 41 of 42 stones were removed during a follow-up period of 9 +/- 2 months; in contrast, no patient in the control group had complete clearance and only 6 of 40 stones were removed after a follow-up period of 31 +/- 6 months. Oral ursodeoxycholic acid facilitates extraction of defiant bile duct stones. This treatment is an effective alternative to high-tech extraction methods for large biliary stones.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8365601     DOI: 10.1016/s0016-5107(93)70164-9

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  7 in total

1.  Retained common bile duct stones after endoscopic sphincterotomy: temporary and longterm treatment with biliary stenting.

Authors:  D G Maxton; D E Tweedle; D F Martin
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

2.  Bacteria involved in the blockage of biliary stents and their susceptibility to antibacterial agents.

Authors:  G Molinari; V Pugliese; G C Schito; C A Guzmán
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

3.  The Stent Patency and Migration Rate of Different Shaped Plastic Stents in Bile Flow Phantom Model and In Vivo Animal Bile Duct Dilation Model.

Authors:  Chang-Il Kwon; Gwangil Kim; Seok Jeong; Don Haeng Lee; Kyoung Ah Kim; Kwang Hyun Ko; Joo Young Cho; Sung Pyo Hong
Journal:  Dig Dis Sci       Date:  2017-03-09       Impact factor: 3.199

4.  Roles of ursodeoxycholic acid in the bile biochemistry and metabolomics in patients with choledocholithiasis: a prospective study.

Authors:  Yaping Guan; Fei Xu; Xiaodong Zhang; Xiao Fu; Jing Wang; Sentao Song; Yan Sun; Qiongying Yuan; Feng Zhu
Journal:  Metabolomics       Date:  2022-07-01       Impact factor: 4.747

Review 5.  Biliary Strictures: Etiologies and Medical Management.

Authors:  Terrance Rodrigues; Justin R Boike
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

6.  Clinical spotlight review for the management of choledocholithiasis.

Authors:  Vimal K Narula; Eleanor C Fung; D Wayne Overby; William Richardson; Dimitrios Stefanidis
Journal:  Surg Endosc       Date:  2020-02-24       Impact factor: 4.584

7.  Difficult bile duct stones.

Authors:  Lee McHenry; Glen Lehman
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.